- Home
- SLRX vs SPRC Comparison
SLRX vs SPRC Comparison
Compare SLRX & SPRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLRX
- SPRC
- Stock Information
- Founded
- SLRX N/A
- SPRC 2004
- Country
- SLRX United States
- SPRC Israel
- Employees
- SLRX N/A
- SPRC N/A
- Industry
- SLRX Biotechnology: Pharmaceutical Preparations
- SPRC Biotechnology: Pharmaceutical Preparations
- Sector
- SLRX Health Care
- SPRC Health Care
- Exchange
- SLRX Nasdaq
- SPRC Nasdaq
- Market Cap
- SLRX 2.9M
- SPRC 3.0M
- IPO Year
- SLRX N/A
- SPRC N/A
- Fundamental
- Price
- SLRX $4.65
- SPRC $2.27
- Analyst Decision
- SLRX
- SPRC
- Analyst Count
- SLRX 0
- SPRC 0
- Target Price
- SLRX N/A
- SPRC N/A
- AVG Volume (30 Days)
- SLRX 124.5K
- SPRC 981.3K
- Earning Date
- SLRX 08-12-2025
- SPRC 01-01-0001
- Dividend Yield
- SLRX N/A
- SPRC N/A
- EPS Growth
- SLRX N/A
- SPRC N/A
- EPS
- SLRX N/A
- SPRC N/A
- Revenue
- SLRX N/A
- SPRC $1,306,000.00
- Revenue This Year
- SLRX N/A
- SPRC N/A
- Revenue Next Year
- SLRX N/A
- SPRC N/A
- P/E Ratio
- SLRX N/A
- SPRC N/A
- Revenue Growth
- SLRX N/A
- SPRC N/A
- 52 Week Low
- SLRX $4.61
- SPRC $2.00
- 52 Week High
- SLRX $108.00
- SPRC $37.59
- Technical
- Relative Strength Index (RSI)
- SLRX 31.39
- SPRC 20.75
- Support Level
- SLRX $4.61
- SPRC $2.00
- Resistance Level
- SLRX $6.28
- SPRC $2.41
- Average True Range (ATR)
- SLRX 0.54
- SPRC 0.53
- MACD
- SLRX 0.05
- SPRC -0.13
- Stochastic Oscillator
- SLRX 1.92
- SPRC 8.47
About SLRX Salarius Pharmaceuticals Inc.
Salarius Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing effective treatments for cancers with high, unmet medical needs. The company has focused on two classes of drugs that address gene dysregulation: targeted protein inhibitors and targeted protein degradation. Its Pipeline includes seclidemstat (SP-2577), a small molecular inhibitor, and SP-3164, a small molecular protein degrader.
About SPRC SciSparc Ltd.
SciSparc Ltd is a specialty clinical stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.